NousCom
NousCom is a viral vector-based cancer vaccines developer founded in 2015.
4
Funding Rounds
$120.5m
Money raised
Overview
NousCom is a viral vector-based cancer vaccines developer founded in 2015.
- Website:
- Business model: B2C
- Headquarters: Basel
- Social accounts: linkedin
Funding
Funding series
Funding Series Analysis
The company NousCom has raised a total of $120.5m in funding over 4 rounds.
Key Insights:
- Nouscom November 2017 Series B Funding Round: $46m
- NousCom Series B round, November 2017: $48.5m
- Nouscom May 2016 Series A Funding Round: $13m
- Nouscom May 2016 Series A Funding Round: $13m
Nouscom November 2017 Series B Funding Round
$46m
NousCom Series B round, November 2017
$48.5m
Nouscom May 2016 Series A Funding Round
$13m
Nouscom May 2016 Series A Funding Round
$13m
Industries
NousCom is active in the following industries: